Yes, if I remember correctly, the Altria collaboration is what`s next. They have until next month (check it to be sure) to decide if they will take the final step and commit to pay Lexaria 11 million dollars, for the righs to use the technology they have; already in market with various applications, mainly in food and beverage.

If they continue with the collaboration, Lexaria will work with Altria to implement the technology within a set of new developed products, not at least nicotine market related products, Altria has set up a new division of "healthy alternative".

What strikes me with this confirmation of the approved patent; it could very well be some of the active partners has been waiting for this. If so, we might have a catalyst within o short time window. Let`s see what happens